SVB Leerink Initiates Coverage on NeuroPace (NASDAQ:NPCE)

Investment analysts at SVB Leerink began coverage on shares of NeuroPace (NASDAQ:NPCE – Get Free Report) in a research note issued to investors on Tuesday, Briefing.com reports. The firm set an “outperform” rating and a $22.00 price target on the stock. SVB Leerink’s price target indicates a potential upside of 49.15% from the company’s previous […]

Related Keywords

United States ,Martha Morrell ,Citigroup Inc ,Cantor Fitzgerald ,Kent Lake Capital ,Morgan Stanley ,Wells Fargo Company ,Neuropace Company Profile ,Vanguard Group Inc ,Jpmorgan Chase Co ,Neuropace Inc ,Get Free Report ,Street Capital ,Wells Fargo ,Lake Capital ,Neuropace Daily ,Neuropace ,Nasdaq Npce ,Npce ,Medical ,Initiated Coverage ,Svb Leerink Llc ,